S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study

Area of Science:

• Biochemistry
• Virology
• Oncology

Background:

• Novel coronavirus disease 2019 (COVID-19) poses a significant global health threat, particularly to vulnerable populations including the elderly and those with pre-existing conditions like cancer.
• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes its spike protein, specifically the S2 subunit, for viral entry and replication.
• Tumor suppressor proteins, such as p53 and BRCA-1/2, play critical roles in maintaining genomic stability and preventing cancer development.

Discussion:

• This research investigates the potential molecular interactions between the SARS-CoV-2 S2 subunit and key human tumor suppressor proteins, p53 and BRCA-1/2.
• Bioinformatic analysis was employed to predict and analyze these interactions at a molecular level.
• Understanding these interactions could elucidate novel mechanisms by which SARS-CoV-2 might influence cancer progression or patient outcomes.

Key Insights:

• For the first time, this study reports potential interactions between the SARS-CoV-2 S2 subunit and tumor suppressor proteins p53 and BRCA-1/2.
• The bioinformatic analysis provides preliminary evidence for these molecular associations.
• These findings suggest a potential link between SARS-CoV-2 infection and cellular processes regulated by tumor suppressors.

Outlook:

• Further experimental validation is required to confirm the reported interactions and elucidate their functional consequences.
• This research opens new avenues for investigating the impact of SARS-CoV-2 on cancer biology and patient health.
• Future studies could explore therapeutic strategies targeting these interactions to mitigate COVID-19's effects in cancer patients.